Avenue Therapeutics Inc [ATXI] Insider Activity: An Update for Investors
In a filing, Avenue Therapeutics Inc revealed its 10% Owner Davidow Robert L unloaded Company’s shares for reported $49600.0 on Dec 11 ’23. In the deal valued at $0.14 per share,353,000 shares were sold. As a result of this transaction, Davidow Robert L now holds 22,000 shares worth roughly $2640.0. Then, Davidow Robert L sold […]
Positive sentiment towards ATXI reflected by a fall of -7.77% in short interest
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Avenue Therapeutics Inc shares valued at $49,600 were sold by Davidow Robert L on Dec 11 ’23. At $0.14 per share, Davidow Robert L sold 353,000 shares. The insider’s holdings dropped to 22,000 shares […]
Checking in on Avenue Therapeutics Inc (ATXI) after recent insiders movement
Avenue Therapeutics Inc’s recently made public that its 10% Owner Davidow Robert L unloaded Company’s shares for reported $49600.0 on Dec 11 ’23. In the deal valued at $0.14 per share,353,000 shares were sold. As a result of this transaction, Davidow Robert L now holds 22,000 shares worth roughly $3300.0. Then, Davidow Robert L sold […]
A company insider recently sold 353,000 shares of Avenue Therapeutics Inc [ATXI]. Should You Sale?
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Avenue Therapeutics Inc shares valued at $49,600 were sold by Davidow Robert L on Dec 11 ’23. At $0.14 per share, Davidow Robert L sold 353,000 shares. The insider’s holdings dropped to 22,000 shares […]
Taking a Closer Look At Avenue Therapeutics Inc (ATXI) Following Its Recent Trade
Avenue Therapeutics Inc’s filing revealed that its 10% Owner Davidow Robert L unloaded Company’s shares for reported $49600.0 on Dec 11 ’23. In the deal valued at $0.14 per share,353,000 shares were sold. As a result of this transaction, Davidow Robert L now holds 22,000 shares worth roughly $3300.0. Then, Davidow Robert L sold 264,000 […]
Avenue Therapeutics Inc’s latest rating changes from various analysts
Avenue Therapeutics Inc’s filing revealed that its 10% Owner Davidow Robert L unloaded Company’s shares for reported $49600.0 on Dec 11 ’23. In the deal valued at $0.14 per share,353,000 shares were sold. As a result of this transaction, Davidow Robert L now holds 22,000 shares worth roughly $3300.0. Then, Davidow Robert L sold 264,000 […]
